Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

NCT00110422 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Syndrome
Hypertension

Interventions

DRUG: Irbesartan
DRUG: Hydrochlorothiazide

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]